| What is subjective global assessment of nutritional status? AS Detsky, JR McLaughlin, JP Baker, N Johnston, S Whittaker, ... Journal of parenteral and enteral nutrition 11 (1), 8-13, 1987 | 4945 | 1987 |
| Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women EARLY BREAST CANCER TRIALISTS'COLLABORATIVE GROUP The Lancet 339 (8784), 1-15, 1992 | 2666 | 1992 |
| Polychemotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 352 (9132), 930-942, 1998 | 2160 | 1998 |
| STrengthening the REporting of Genetic Association Studies (STREGA)—an extension of the STROBE statement J Little, JPT Higgins, JPA Ioannidis, D Moher, F Gagnon, E Von Elm, ... Genetic Epidemiology: The Official Publication of the International Genetic …, 2009 | 1501 | 2009 |
| A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 RJ Hung, JD McKay, V Gaborieau, P Boffetta, M Hashibe, D Zaridze, ... Nature 452 (7187), 633-637, 2008 | 1496 | 2008 |
| Effects of radiotherapy and surgery in early breast cancer—an overview of the randomized trials Early Breast Cancer Trialists' Collaborative Group N Engl j med 1995 (333), 1444-1456, 1995 | 1252 | 1995 |
| Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer HA Risch, JR McLaughlin, DEC Cole, B Rosen, L Bradley, E Kwan, ... The American Journal of Human Genetics 68 (3), 700-710, 2001 | 1248 | 2001 |
| Carcinogenicity of tetrachlorvinphos, parathion, malathion, diazinon, and glyphosate KZ Guyton, D Loomis, Y Grosse, F El Ghissassi, L Benbrahim-Tallaa, ... The Lancet Oncology 16 (5), 490-491, 2015 | 1106 | 2015 |
| SYSTEMIC TREATMENT OF EARLY BREAST-CANCER BY HORMONAL, CYTOTOXIC, OR IMMUNE THERAPY-133 RANDOMIZED TRIALS INVOLVING 31000 RECURRENCES AND 24000 DEATHS AMONG 75000 WOMEN. Part 2. O Abe, R Abe, K Asaishi, K Enomoto, T Hattori, Y Ino, K Kikuchi, ... Lancet 339 (8785), 71-85, 1992 | 1087 | 1992 |
| Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin–cohort study in Ontario, Canada HA Risch, JR McLaughlin, DEC Cole, B Rosen, L Bradley, I Fan, J Tang, ... Journal of the National Cancer Institute 98 (23), 1694-1706, 2006 | 938 | 2006 |
| Predicting cardiac complications in patients undergoing non-cardiac surgery AS Detsky, HB Abrams, JR McLaughlin, DJ Drucker, Z Sasson, ... Journal of general internal medicine 1 (4), 211-219, 1986 | 922 | 1986 |
| Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24 BW Zanke, CMT Greenwood, J Rangrej, R Kustra, A Tenesa, ... Nature genetics 39 (8), 989-994, 2007 | 829 | 2007 |
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 662 | 2013 |
| Lung cancer susceptibility locus at 5p15. 33 JD McKay, RJ Hung, V Gaborieau, P Boffetta, A Chabrier, G Byrnes, ... Nature genetics 40 (12), 1404-1406, 2008 | 660 | 2008 |
| Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007 S Walters, C Maringe, MP Coleman, MD Peake, J Butler, N Young, ... Thorax 68 (6), 551-564, 2013 | 628 | 2013 |
| A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma MT Landi, N Chatterjee, K Yu, LR Goldin, AM Goldstein, M Rotunno, ... The american journal of human genetics 85 (5), 679-691, 2009 | 609 | 2009 |
| Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes JD McKay, RJ Hung, Y Han, X Zong, R Carreras-Torres, DC Christiani, ... Nature genetics 49 (7), 1126-1132, 2017 | 607 | 2017 |
| Ovarian ablation in early breast cancer: overview of the randomised trials EBCTC Group Lancet 348 (9036), 1189-1196, 1996 | 587 | 1996 |
| Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer S Zhang, R Royer, S Li, JR McLaughlin, B Rosen, HA Risch, I Fan, ... Gynecologic oncology 121 (2), 353-357, 2011 | 523 | 2011 |
| Non-Hodgkin’s lymphoma and specific pesticide exposures in men: cross-Canada study of pesticides and health HH McDuffie, P Pahwa, JR McLaughlin, JJ Spinelli, S Fincham, ... Cancer Epidemiology Biomarkers & Prevention 10 (11), 1155-1163, 2001 | 454 | 2001 |
Steven NarodCanada Research Chair in Breast Cancer; Director, Familial Breast Cancer Research Unit, WCRIایمیل تأیید شده در wchospital.ca